Items where authors include "Fylan, B"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 19.

Article

Peat, G, Fylan, B, Breen, L et al. (3 more authors) (2023) Person-centred deprescribing for patients living with frailty: a qualitative interview study and proposal of a collaborative model. International Journal of Pharmacy Practice, 31 (3). pp. 282-289. ISSN 0961-7671

Albutt, A, Ramsey, L, Fylan, B et al. (3 more authors) (2023) Patient and public co‐creation of healthcare safety and healthcare system resilience: The case of COVID‐19. Health Expectations. ISSN 1369-6513

Okeowo, DA, Zaidi, STR, Fylan, B et al. (1 more author) (2023) Barriers and facilitators of implementing proactive deprescribing within primary care: a systematic review. International Journal of Pharmacy Practice, 31 (2). riad001. pp. 126-152. ISSN 0961-7671

Previdoli, G, Cheong, V-L, Alldred, D orcid.org/0000-0002-2525-4854 et al. (5 more authors) (2023) A rapid review of interventions to improve medicine self-management for older people living at home. Health Expectations. ISSN 1369-6513

Silcock, J, Marques, I, Olaniyan, J et al. (9 more authors) (2023) Co-designing an intervention to improve the process of deprescribing for older people living with frailty in the UK. Health Expectations, 26 (1). pp. 399-408. ISSN 1369-6513

Fylan, B, Munro, J, O'Hara, JK orcid.org/0000-0001-5551-9975 et al. (2 more authors) (2023) Developing a research community within an online healthcare feedback platform. Health Expectations. ISSN 1369-6513

Powell, C, Ismail, H, Davis, M et al. (8 more authors) (2022) Experiences of patients with heart failure with a Medicines at Transition Intervention: findings from the process evaluation of the Improving the Safety and Continuity of Medicines management at Transitions of care (ISCOMAT) programme. Health Expectations, 25 (5). pp. 2503-2514. ISSN 1369-6513

Peat, G, Olaniyan, J, Fylan, B et al. (4 more authors) (2022) Mapping the resilience performance of community pharmacy to maintain patient safety during the Covid-19 pandemic. Research in Social and Administrative Pharmacy, 18 (9). pp. 3534-3541. ISSN 1551-7411

Jameson, A, Fylan, B, Bristow, G et al. (5 more authors) (2022) Pharmacogenomics is the future of prescribing in psychiatry. Pharmaceutical Journal, 309. 7964. ISSN 2053-6186

Moreau, LA, Holloway, I, Fylan, B et al. (15 more authors) (2022) Using routine healthcare data to evaluate the impact of the Medicines at Transitions Intervention (MaTI) on clinical outcomes of patients hospitalised with heart failure: protocol for the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trial with embedded process evaluation, health economics evaluation and internal pilot. BMJ Open, 12 (4). e054274. ISSN 2044-6055

Peat, G, Fylan, B, Marques, I et al. (4 more authors) (2022) Barriers and facilitators of successful deprescribing as described by older patients living with frailty, their informal carers and clinicians: a qualitative interview study. BMJ Open, 12 (3). e054279. ISSN 2044-6055

Jameson, A, Fylan, B, Bristow, GC et al. (5 more authors) (2021) What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings? Frontiers in Genetics, 12. 740216. ISSN 1664-8021

Powell, C, Ismail, H, Cleverley, R et al. (5 more authors) (2021) Patients as qualitative data analysts: developing a method for a process evaluation of the ‘Improving the Safety and Continuity Of Medicines management at care Transitions’ (ISCOMAT) randomised controlled trial. Health Expectations, 24 (4). pp. 1254-1262. ISSN 1369-6513

David, V, Fylan, B, Bryant, E et al. (3 more authors) (2021) An Analysis of Pharmacogenomic-Guided Pathways and Their Effect on Medication Changes and Hospital Admissions: A Systematic Review and Meta-Analysis. Frontiers in Genetics, 12. 698148. ISSN 1664-8021

Fylan, B, Tomlinson, J, Raynor, DK orcid.org/0000-0003-0306-5275 et al. (1 more author) (2021) Using experience-based co-design with patients, carers and healthcare professionals to develop theory-based interventions for safer medicines use. Research in Social and Administrative Pharmacy. ISSN 1551-7411

Fylan, B, Ismail, H, Hartley, S et al. (5 more authors) (2021) A non-randomised feasibility study of an intervention to optimise medicines at transitions of care for patients with heart failure. Pilot and Feasibility Studies, 7 (1). 85. ISSN 2055-5784

Powell, C, Breen, L, Fylan, B et al. (6 more authors) (2020) Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT): protocol for a process evaluation of a cluster randomised control trial. BMJ Open, 10 (11). e040493. ISSN 2044-6055

Raynor, DK orcid.org/0000-0003-0306-5275, Ismail, H, Blenkinsopp, A et al. (3 more authors) (2020) Experience‐based co‐design—Adapting the method for a researcher‐initiated study in a multi‐site setting. Health Expectations, 23 (3). pp. 562-570. ISSN 1369-6513

Fylan, B, Marques, I, Ismail, H et al. (4 more authors) (2019) Gaps, traps, bridges and props: a mixed-methods study of resilience in the medicines management system for patients with heart failure at hospital discharge. BMJ Open, 9 (2). e023440. ISSN 2044-6055

This list was generated on Sat Mar 23 17:23:54 2024 GMT.